A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Minnesota's Tim Walz Tapped as Kamala Harris's Running Mate: A Strategic Move for Broader Appeal
Chelsea U18s Hold West Ham to Thrilling 2-2 Draw in Premier League Clash
Arsenal Looks to Overcome Injuries in Crucial Premier League Clash Against Ipswich Town
Bukayo Saka Poised to Make Premier League History Against Manchester City
Victor Boniface Escapes Major Injury in Serious Car Accident Confirmed by Bayer Leverkusen
